Intensive chemotherapy for poor prognosis myelodysplasia (MDS) and secondary acute myeloid leukemia (sAML) following MDS of more than 6 months duration. A pilot study by the Leukemia Cooperative Group.

There is no fulltext present in this item.

Title:	Intensive chemotherapy for poor prognosis myelodysplasia (MDS) and secondary acute myeloid leukemia (sAML) following MDS of more than 6 months duration. A pilot study by the Leukemia Cooperative Group.
Author(s):	Witte, T.J.M. de ; Suciu, S.; Peetermans, M.; Fenaux, P.; Strijckmans, P.; Hayat, M.; Jaksic, B.; Selleslag, S.; Zittoun, R.; Dardenne, M.; Solbu, G.; Zwierzina, H.; Muus, P.
Publication year:	1995
Source:	Leukemia, vol. 9, (1995), pp. 1805-1811
ISSN:	0887-6924
Publication type:	Article / Letter to editor
Please use this identifier to cite or link to this item : https://hdl.handle.net/2066/189300
Display more details
Subject:	Immunophenotype of leukemic clonogenic cells with "self-renewal" capacity (stem cells) in "single cell assays" Immunofenotypering van leukemische clonogene cellen met "self-renewal" capaciteit (stamcellen) in "single c;ass assays" ren
Organization:	Haematology
Journal title:	Leukemia
Volume:	vol. 9
Page start:	p. 1805
Page end:	p. 1811